Sui, Shijia
Bian, Shijun
Xia, Zhikuan
Wu, Jiamin
Fan, Yunlong
Wang, Xudong
Liu, Xukui
Li, Haitao
Yang, Rongya
Article History
Received: 29 December 2025
Accepted: 22 June 2026
First Online: 16 July 2026
Declarations
Ethics approval: All animal experimental protocols were approved by Beijing Yangfang Boyi Biotechnology Co., Ltd. (approval number: YFBY-FL-2024-005). All experiments involving human participants were conducted in accordance with the Declaration of Helsinki. and received ethical approval from the Ethics Committee of the Seventh Medical Center of Chinese PLA General Hospital (approval no: S2025-135-01). Clinical trial number: not applicable.
Consent to participate: All authors have read and agreed to submit the manuscript.
Competing interests: The authors declare no competing interests.